This review investigates the ramifications of conflict on chemotherapy drug accessibility for cancer patients in Sudan. For this review article, the data was collected from file records Port Sudan Oncology Center, Port Sudan, Sudan. Through a comprehensive analysis of drug supply frequencies during distinct conflict periods, the study reveals fluctuating availability and challenges in sustaining the supply chain. Grouping chemotherapy drugs according to their availability patterns elucidates the varying degrees of accessibility during conflict, ranging from consistent supplies to complete absence. The impact of these shortages on cancer patients is profound, resulting in compromised treatment outcomes, increased morbidity and mortality rates, and substantial socioeconomic burdens. Real-life patient accounts underscore the emotional, physical, and financial toll imposed by interrupted access to vital medications. Despite efforts by healthcare institutions, NGOs, and governmental bodies, persistent challenges hinder effective mitigation strategies during conflict, including logistical constraints, inadequate funding, and political instability. The socioeconomic and psychological implications of drug shortages are significant, pushing patients deeper into poverty and exacerbating psychological distress. Addressing these challenges necessitates sustained efforts to fortify drug supply chains, enhance infrastructure, and foster multi-stakeholder cooperation. The study emphasises the critical need for sustained interventions to ensure continuous access to chemotherapy drugs in Sudan and conflict zones globally. Immediate actions are imperative to alleviate the burdens faced by cancer patients and fortify healthcare systems to withstand the challenges of conflict-induced drug scarcity.
Read full abstract